Editorial: Not Yet Time for Universal Susceptibility-Guided First-Line Helicobacter Pylori Treatment

Alimentary Pharmacology and Therapeutics- United Kingdom

doi 10.1111/apt.15302

Full Text

Abstract

Available in

Categories

Gastroenterology

Date

July 17, 2019

Authors

Erick A. Argueta

Publisher

Wiley

Related search

Editorial: Not Yet Time for Universal Susceptibility-Guided First-Line Helicobacter Pylori Treatment-Authors' Reply

Alimentary Pharmacology and Therapeutics

Gastroenterology

English

Different Treatment Choice for First-Line Treatment of Helicobacter Pylori in an Area With a High Antibiotic Resistance

Turkish Journal of Gastroenterology

Gastroenterology

English

Efficacy of Potassium-Competitive Acid Blocker vs Proton Pump Inhibitor as First-Line and Second-Line Treatment for Helicobacter Pylori Eradication

Open Journal of Gastroenterology and Hepatology

English

Adding Bismuth to Rabeprazole-Based First-Line Triple Therapy Does Not Improve the Eradication of Helicobacter Pylori

Gastroenterology Research and Practice

Gastroenterology

English

Clinical Efficacy of Gemifloxacin-Containing Triple Therapy for First-Line Treatment of Helicobacter Pylori Infection: A Pilot Study

The Korean Journal of Helicobacter and Upper Gastrointestinal Research

English

Lactobacillus Reuteri – An Alternative in the First-Line of Helicobacter Pylori Eradication

English

14 Day-Sequential, Concomitant, and Hybrid Therapies for First-Line Helicobacter Pylori (H. PYLORI) Eradication: A Network Meta-Analysis

Value in Health

Occupational Health

English

First-Line Helicobacter Pylori Eradication in Patients With Chronic Kidney Diseases in Taiwan

BioMed Research International

Molecular Biology

English

Treatment of Helicobacter Pylori Infection

Infectious Diseases

Gastroenterology

English